Toward an Understanding of the Pathophysiology of Clear Cell Carcinoma of the Ovary (Review)

Overview

Journal Oncol Lett

Specialty Oncology

Date 2013 Nov 2

PMID 24179489

Citations 8

Authors

Chiharu Uekuri

Hiroshi Shigetomi

Sumire Ono

Yoshikazu Sasaki

Miyuki Matsuura

Hiroshi Kobayashi

Affiliations

Soon will be listed here.

Abstract

Endometriosis-associated ovarian cancers demonstrate substantial morphological and genetic diversity. The transcription factor, hepatocyte nuclear factor (HNF)-1β, may be one of several key genes involved in the identity of ovarian clear cell carcinoma (CCC). The present study reviews a considerably expanded set of HNF-1β-associated genes and proteins that determine the pathophysiology of CCC. The current literature was reviewed by searching MEDLINE/PubMed. Functional interpretations of gene expression profiling in CCC are provided. Several important CCC-related genes overlap with those known to be regulated by the upregulation of HNF-1β expression, along with a lack of estrogen receptor (ER) expression. Furthermore, the genetic expression pattern in CCC resembles that of the Arias-Stella reaction, decidualization and placentation. HNF-1β regulates a subset of progesterone target genes. HNF-1β may also act as a modulator of female reproduction, playing a role in endometrial regeneration, differentiation, decidualization, glycogen synthesis, detoxification, cell cycle regulation, implantation, uterine receptivity and a successful pregnancy. In conclusion, the present study focused on reviewing the aberrant expression of CCC-specific genes and provided an update on the pathological implications and molecular functions of well-characterized CCC-specific genes.

Citing Articles

Thyroid metastasis from ovarian clear cell carcinoma.

Sasaki R, Yamazaki H, Kumagai E, Toda S, Saito A Endocrinol Diabetes Metab Case Rep. 2024; 2024(4.

PMID: 39700333 PMC: 11737430. DOI: 10.1530/EDM-24-0086.

p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway.

Liu M, Wang Y, Xu X, Guan G, Zhang S, Zhu S Front Pharmacol. 2024; 15:1448863.

PMID: 39650157 PMC: 11622497. DOI: 10.3389/fphar.2024.1448863.

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes.

Feeney L, Harley I, McCluggage W, Mullan P, Beirne J World J Clin Oncol. 2020; 11(11):868-889.

PMID: 33312883 PMC: 7701910. DOI: 10.5306/wjco.v11.i11.868.

Altered Organelle Calcium Transport in Ovarian Physiology and Cancer.

Caravia L, Staicu C, Radu B, Condrat C, Cretoiu D, Bacalbasa N Cancers (Basel). 2020; 12(8).

PMID: 32785177 PMC: 7464720. DOI: 10.3390/cancers12082232.

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.

Khan T, He Y, Kryza T, Harrington B, Gunter J, Sullivan M Cancers (Basel). 2020; 12(4).

PMID: 32260077 PMC: 7226162. DOI: 10.3390/cancers12040869.

References

Fraga-Silva R, Costa-Fraga F, Murca T, Moraes P, Martins Lima A, Lautner R . Angiotensin-converting enzyme 2 activation improves endothelial function. Hypertension. 2013; 61(6):1233-8. PMC: 3733257. DOI: 10.1161/HYPERTENSIONAHA.111.00627. View

Uchida H, Maruyama T, Nishikawa-Uchida S, Oda H, Miyazaki K, Yamasaki A . Studies using an in vitro model show evidence of involvement of epithelial-mesenchymal transition of human endometrial epithelial cells in human embryo implantation. J Biol Chem. 2011; 287(7):4441-50. PMC: 3281640. DOI: 10.1074/jbc.M111.286138. View

Kim A, Enomoto T, Serada S, Ueda Y, Takahashi T, Ripley B . Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Int J Cancer. 2009; 125(10):2316-22. DOI: 10.1002/ijc.24587. View

Pectasides D, Pectasides E, Psyrri A, Economopoulos T . Treatment issues in clear cell carcinoma of the ovary: a different entity?. Oncologist. 2006; 11(10):1089-94. DOI: 10.1634/theoncologist.11-10-1089. View

Toyokuni S . Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr. 2011; 48(1):46-9. PMC: 3022063. DOI: 10.3164/jcbn.11-001FR. View

Gutgemann I, Lehman N, Jackson P, Longacre T . Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Mod Pathol. 2008; 21(4):445-54. DOI: 10.1038/modpathol.3801022. View

Kuo K, Mao T, Chen X, Feng Y, Nakayama K, Wang Y . DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma. Clin Cancer Res. 2010; 16(7):1997-2008. PMC: 2848895. DOI: 10.1158/1078-0432.CCR-09-2105. View

Sugita S, Morishita Y, Kano J, Furuya S, Shiba-Ishii A, Noguchi M . IGFBP-1 is expressed specifically in ovarian clear cell adenocarcinoma. Histopathology. 2011; 58(5):729-38. DOI: 10.1111/j.1365-2559.2011.03817.x. View

Ogata K, Shimamura Y, Hamada K, Hisa M, Bun M, Okada N . Upregulation of HNF-1β during experimental acute kidney injury plays a crucial role in renal tubule regeneration. Am J Physiol Renal Physiol. 2012; 303(5):F689-99. DOI: 10.1152/ajprenal.00086.2012. View

10.

Kerschner J, Harris A . Transcriptional networks driving enhancer function in the CFTR gene. Biochem J. 2012; 446(2):203-12. PMC: 3419791. DOI: 10.1042/BJ20120693. View

11.

Yamada Y, Shigetomi H, Onogi A, Haruta S, Kawaguchi R, Yoshida S . Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer. 2011; 21(7):1200-7. DOI: 10.1097/IGC.0b013e318222cfdd. View

12.

Itamochi H, Kigawa J, Akeshima R, Sato S, Kamazawa S, Takahashi M . Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary. Oncology. 2002; 62(4):349-53. DOI: 10.1159/000065067. View

13.

DeLair D, Oliva E, Kobel M, Macias A, Gilks C, Soslow R . Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol. 2010; 35(1):36-44. DOI: 10.1097/PAS.0b013e3181ff400e. View

14.

Collins Y, DiCioccio R, Keitz B, Lele S, Odunsi K . Methylation of death-associated protein kinase in ovarian carcinomas. Int J Gynecol Cancer. 2006; 16 Suppl 1:195-9. DOI: 10.1111/j.1525-1438.2006.00506.x. View

15.

Wareing M, Greenwood S . Review: Potassium channels in the human fetoplacental vasculature. Placenta. 2011; 32 Suppl 2:S203-6. DOI: 10.1016/j.placenta.2010.12.022. View

16.

Dimitriadis E, Stoikos C, Tan Y, Salamonsen L . Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. Endocrinology. 2006; 147(8):3809-17. DOI: 10.1210/en.2006-0264. View

17.

Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I . Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett. 2011; 310(2):129-33. DOI: 10.1016/j.canlet.2011.06.039. View

18.

Min K, Park M, Hong S, Lee H, Kwon S, Hong S . Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3. Int J Gynecol Pathol. 2012; 32(1):3-14. DOI: 10.1097/PGP.0b013e31825554e9. View

19.

Tamada Y, Takeuchi H, Suzuki N, Susumu N, Aoki D, Irimura T . Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary. Cancer Sci. 2007; 98(10):1586-91. PMC: 11159453. DOI: 10.1111/j.1349-7006.2007.00582.x. View

20.

Xu J, Wang Y, Ge F, Lin L, Liu Z, Sharma M . Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms. World J Gastroenterol. 2013; 19(24):3899-903. PMC: 3699040. DOI: 10.3748/wjg.v19.i24.3899. View